Pieper R O, Futscher B W, Erickson L C
Section of Hematology/Oncology, Stritch School of Medicine, Loyola University of Chicago, Maywood, IL 60153.
Carcinogenesis. 1989 Jul;10(7):1307-14. doi: 10.1093/carcin/10.7.1307.
The present study was initiated to determine if DNA damage induced by the bifunctional anti-tumor alkylating agents melphalan, nitrogen mustard, a spontaneously activated derivative of cyclophosphamide or chlorambucil inhibits transcription in vitro, and to determine if the potential sites of transcription termination correlate with the sites of N7 guanine adducts predominantly formed by these agents. To assess drug effects on in vitro transcription, linearized plasmid DNA containing the 420-bp PstI fragment of exon two of the human c-myc oncogene was incubated with various concentrations of the drugs. After drug removal and further drug-free incubation, the sense strand of the c-myc insert was transcribed with either of two bacteriophage RNA polymerases in the presence of [32P]UTP. The labeled products of the reaction were electrophoresed next to the labeled products of RNA sequencing reactions, and the location of transcription termination along the DNA template was determined. The sites of transcription termination were then compared with the sites of drug-induced guanine N7 alkylation in the template, as determined by modified Maxam-Gilbert sequencing. At the drug exposures examined, all the drugs were shown to alkylate any guanine in the template. Transcription of this alkylated DNA, however, resulted in RNA molecules truncated not at every alkylated guanine, but at various discrete sites throughout the template. Transcription was terminated at every adenine pair examined in the melphalan-treated template, at selected guanine pairs in the nitrogen-mustard-treated template, and at selected adenine-guanine and guanine-adenine pairs in the chlorambucil-treated template. Transcription of cyclophosphamide-derivative-treated DNA was unaffected. These results suggest that only some bifunctional alkylating agents induce DNA damage capable of terminating transcription in vitro, and that these agents do so in a sequence-specific, drug-specific manner inconsistent with patterns of guanine N7 alkylation.
开展本研究的目的是确定双功能抗肿瘤烷化剂美法仑、氮芥、环磷酰胺的一种自发活化衍生物或苯丁酸氮芥所诱导的DNA损伤是否会在体外抑制转录,以及确定转录终止的潜在位点是否与这些药物主要形成的N7鸟嘌呤加合物位点相关。为了评估药物对体外转录的影响,将含有人类c-myc癌基因外显子2的420 bp PstI片段的线性化质粒DNA与不同浓度的药物一起孵育。去除药物并进一步进行无药物孵育后,在[32P]UTP存在的情况下,用两种噬菌体RNA聚合酶之一转录c-myc插入片段的有义链。将反应的标记产物与RNA测序反应的标记产物一起进行电泳,并确定沿DNA模板的转录终止位置。然后将转录终止位点与模板中药物诱导的鸟嘌呤N7烷基化位点进行比较,后者通过改良的Maxam-Gilbert测序法确定。在所检测的药物暴露条件下,所有药物均显示会使模板中的任何鸟嘌呤烷基化。然而,这种烷基化DNA的转录产生的RNA分子并非在每个烷基化鸟嘌呤处截断,而是在模板中的各个离散位点截断。在美法仑处理的模板中,在所检测的每个腺嘌呤对处转录终止;在氮芥处理的模板中,在选定的鸟嘌呤对处转录终止;在苯丁酸氮芥处理的模板中,在选定的腺嘌呤-鸟嘌呤和鸟嘌呤-腺嘌呤对处转录终止。环磷酰胺衍生物处理的DNA的转录未受影响。这些结果表明,只有一些双功能烷化剂会诱导能够在体外终止转录的DNA损伤,并且这些药物以与鸟嘌呤N7烷基化模式不一致的序列特异性、药物特异性方式导致这种损伤。